Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

about

Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells.Cell and Gene Therapy for HIV Cure.

P2860

Q33635315-F2C5F8C6-6ED9-4E5B-8341-C225717ECDAA Q47236016-113A56C5-05B9-4CC3-BDF9-AFCA0E7D7CCA

P2860

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

Item

http://www.wikidata.org/entity/Q38800411

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

@en

type

Item

label

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

@en

prefLabel

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

@en

P1476

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

@en

P2093

Anjali Joshi

http://www.w3.org/2001/XMLSchema#string

Himanshu Garg

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection

Gene transfer in humans using a conditionally replicating lentiviral vector

Continuous cultures of fused cells secreting antibody of predefined specificity

Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?

Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice

Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

Control of HIV-1 replication in elite suppressors

CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection

Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection

P304

400-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2015.126

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26800572

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4841074

http://www.w3.org/2001/XMLSchema#string

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

about

P2860

P2860

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932